Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8637538

Methods for treatment of pruritis

Trevi Therapeutics, Inc. · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8636988

Composition for treatment of sunburned skin

Doctor Essentials · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8629127

Compositions and methods of treatment for inflammatory diseases

The Regents of the University of Oklahoma · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8629119

Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders

The Board of Regents of the University of Texas System · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8623330

Emollient foams for treatment of seborrheic dermatitis

Precision Dermatology, Inc. · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8623847

Compositions for treatment of inflammatory diseases

The Regents of the University of Oklahoma · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8616429

Structure containing wound treatment material

Covidien LP · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8618080

Immunomodulatory compounds and treatment of diseases related to an overproduction of infla

OM PHARMA · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8618058

Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

Soricimed Biopharma Inc. · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8614179

Antibacterial combination therapy for the treatment of gram positive bacterial infections

E-Therapeutics PLC · Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609728

Treatment for pulmonary hypertension

United Therapeutics Corporation · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609088

Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment

Regents of the University of Minnesota · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8604011

Therapy for treatment of chronic degenerative brain diseases and nervous system injury

The Regents of the University of California · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8603462

Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal

The United States of America—Department of Veterans Affairs · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8598203

Treatment of Crohn's disease with laquinimod

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8592456

IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

4SC DISCOVERY GMBH · Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8591890

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment mo

University of Connecticut Health Center · Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8591922

Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

Jazz Pharmaceuticals, Inc. · Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8586044

Treatment of chronic pelvic pain syndrome

Northwestern University · Granted Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580748

Peptides for the treatment of hearing

Compass Therapeutics LLC · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580735

Local complement inhibition for treatment of complement-mediated disorders

Apellis Pharmaceuticals, Inc. · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580249

Cell therapy for the treatment of lysosomal storage disorders

Regents of the University of Minnesota · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580738

Methods for treatment of reperfusion injury and other cardiac conditions

The Board of Regents of the University of Texas System · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575312

Compositions and methods of use for MGD-CSF in disease treatment

Five Prime Therapeutics, Inc. · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted